MyAmyloidosisTeam

Has Amvuttra (vutrisiran) received FDA approval for wild-type ATTR amyloidosis? This is a great question worth clarifying.

As of March 2025, the FDA approved Amvuttra (vutrisiran) specifically for transthyretin amyloid cardiomyopathy (ATTR-CM). This is significant news for the amyloidosis community! It's worth noting that Show Full Answer

Has Amvuttra (vutrisiran) received FDA approval for wild-type ATTR amyloidosis? This is a great question worth clarifying.

As of March 2025, the FDA approved Amvuttra (vutrisiran) specifically for transthyretin amyloid cardiomyopathy (ATTR-CM). This is significant news for the amyloidosis community! It's worth noting that wild-type ATTR amyloidosis is one form of ATTR-CM, so this approval is relevant to those living with wild-type ATTR.

However, it's important to speak with your specialist to confirm whether Amvuttra is appropriate for your specific situation, as treatment decisions are always made on a case-by-case basis. Your doctor can help determine the best path forward based on your individual health history and needs.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

8 Amyloidosis Treatments and Their Side Effects

hATTR Amyloidosis Treatments: Comparing Your Options